ARGX

Companies
NASDAQ
Argenx SE - American Depositary Receipt
Health Care
Price Chart
Overview

About ARGX

Argenx is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer.

Market Cap
$22.3B
Volume
234.7M
Avg. Volume
197.1M
P/E Ratio
56.224976
Dividend Yield
0.00%
Employees
742.0

Company Information

Exchange
NASDAQ
Sector
Health Care
Industry
Biotechnology
Risk & Correlation Analysis
Market Correlation
0.68
Low Correlation
Volatility
Medium (0.33)
Relative to market

Macro Factor Sensitivities

Interest Rates
Low Sensitivity
Inflation
Low Sensitivity
GDP Growth
Medium Sensitivity
Liquidity
High Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions

Premium Forecasts

Get AI-powered price predictions, technical analysis, and market forecasts for ARGX.

1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential

Technical Analysis

Based on technical indicators and chart patterns, ARGX shows...

AI Sentiment Analysis

Market sentiment analysis indicates...

Key Statistics
Market Cap$22.3B
Volume234.7M
P/E Ratio56.22
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
May 8, 2025

PortfolioPilot Analysis

Get AI-powered insights on how ARGX fits into your investment strategy and portfolio diversification.

Pricing info last updated June 19, 2025 (after market close)Other info last updated April 2, 2025